GSK is a British drugmaker focused on vaccines (Shingrix) and specialty medicines.
GSK plc (GSK) is expected to report earnings on Wednesday, October 28, 2026, before the open. Estimated release time before open. Consensus EPS estimate is $1.33.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-28 | Jun 2026 qtr | $1.27 | $0.22 | — | $8.41B |
| 2026-04-29 | Mar 2026 qtr | $1.16 | $1.24 | +6.9% | $7.63B |
| 2026-02-04 | Dec 2025 qtr | $0.64 | $0.32 | — | $8.62B |
| 2025-10-28 | Sep 2025 qtr | $1.26 | $1.48 | +17.5% | $8.55B |
| 2025-07-30 | Jun 2025 qtr | $1.12 | $0.72 | — | $7.99B |
| 2025-04-30 | Mar 2025 qtr | $1.08 | $0.80 | — | $7.52B |
| 2025-02-05 | Dec 2024 qtr | $0.44 | $0.20 | — | $8.12B |
| 2024-10-30 | Sep 2024 qtr | $1.16 | $-0.03 | — | $8.01B |
GSK has beaten consensus EPS in 2 of its last 2 scored quarters.
GSK pays a quarterly dividend, currently yielding 3.67%.
| Ex-dividend date | Amount | Paid |
|---|---|---|
| 2026-08-14 | $0.4501 | 2026-10-08 |
| 2026-05-15 | $0.455 | 2026-07-09 |
| 2026-02-20 | $0.4776 | 2026-04-09 |
| 2025-11-14 | $0.4331 | 2026-01-08 |
| 2025-08-15 | $0.43 | 2025-10-09 |
| 2025-05-16 | $0.4348 | 2025-07-10 |